Delaware becomes KineMatik Authorised Partner for the KineMatik range of OpenText Content Suite Solutions. Improving Business Processes and Optimising Content, Across all Sectors Cork, Ireland – delaware has just been appointed as a KineMatik Authorised Partner further enhancing the delaware solution offering, to meet the needs of their customers. “We are delighted with this new partnership […]
–Collaboration will be a new service offering for Berry Genomics and entry point for 10x Genomics into the NIPT Market in China– PLEASANTON, Calif. & BEIJING–10x Genomics, Inc., a company focused on accelerating genomic discovery, and Berry Genomics Co. Ltd (SZSE:000710), a company devoted to developing and offering genomic solutions for genetic diseases, today announced […]
— MGI’s BGISEQ-500RS Genetic Sequencer, Forthcoming MGISEQ Genetic Sequencers Compatible with 10x Genomics Solutions— PLEASANTON, Calif. & SHENZHEN, China–10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program. MGI will also ensure that the MGISEQ series genetic […]
QIAGEN’s QuantiFERON-TB customers to gain access to fully automated workflow solution DiaSorin to add novel content to already broad LIAISON menu, over 7,000 systems installed QIAGEN announces milestone of over 40 million QuantiFERON-TB tests since launch Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) and DiaSorin (FTSE Italy […]
Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas CARLSBAD, Calif. & SAN DIEGO–Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms. The best-in-class amplicon technology is highly effective in capturing DNA and […]
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a […]
SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings […]
Signs Master Collaboration Agreement for Assay Development and Manufacturing of Kits Supporting Biomarker Research Programs TUCSON, Ariz. and DARMSTADT, Germany — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration Agreement […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
